Product Information

BRIMONIDINE-TIMOLOL 0.2%-0.5% is a generic product labeled by Somerset Therapeutics, LLC, priced at $1.9993 per ML under NDC 70069065201. Its NADAC has been published 80 times since May 7, 2025.

FDA first approved this application on Sep 10, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BRIMONIDINE-TIMOLOL 0.2%-0.5%

Brimonidine Tartrate and Timolol Maleate
$1.9993per ML

Strength

2; 5 mg/mL; mg/mL

NDC

70069065201

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA216114

FDA Approved

9/10/2024

TE Code

AB

On Market Since

10/10/2024

Pharmacological Classes

Adrenergic alpha-Agonists
Adrenergic beta-Antagonists
alpha-Adrenergic Agonist
beta-Adrenergic Blocker

Price Statistics

The NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has been published 80 times since May 7, 2025, and over the history we have for it it has declined 71.8%. The table below summarizes its recorded NADAC range and movement.

Current price$1.9993 per ML
All-time high$7.0952 (May 14, 2025)
All-time low$1.9993 (Oct 21, 2026)
52-week high$2.8127
52-week low$1.9993
Median price$2.6743
Average price$3.3694
Largest weekly change-19.4% (Sep 17, 2025)
Weeks tracked80
Tracking sinceMay 7, 2025

Price History

1W

0.0%

1M

-7.1%

3M

-25.3%

6M

-21.1%

1Y

-35.8%

3Y

N/A

5Y

N/A

All

-71.8%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BRIMONIDINE-TIMOLOL 0.2%-0.5%?

The current National Average Drug Acquisition Cost (NADAC) for BRIMONIDINE-TIMOLOL 0.2%-0.5%, manufactured by Somerset Therapeutics, LLC, is $1.9993 per ML (NDC 70069065201), effective Nov 11, 2026.

How has the price of BRIMONIDINE-TIMOLOL 0.2%-0.5% changed over time?

Over the history we have for it, the NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has declined 71.8%. It has been tracked across 80 weekly CMS publications since May 7, 2025.

What are the highest and lowest recorded NADAC prices for BRIMONIDINE-TIMOLOL 0.2%-0.5%?

Since May 7, 2025, the NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has ranged from a low of $1.9993 (Oct 21, 2026) to a high of $7.0952 (May 14, 2025), with a median of $2.6743 per ML.

Are there cheaper alternatives to BRIMONIDINE-TIMOLOL 0.2%-0.5%?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BRIMONIDINE-TIMOLOL 0.2%-0.5% in a comparable dosage form, but none are currently priced below it.

Who manufactures BRIMONIDINE-TIMOLOL 0.2%-0.5%?

BRIMONIDINE-TIMOLOL 0.2%-0.5% (NDC 70069065201) is labeled by Somerset Therapeutics, LLC, and CMS classifies it as a generic product.